TTT 3002 is an Orally Active FLT3 Inhibitor for Acute Myeloid Leukemia Research
TTT-3002, a tyrosine kinase inhibitor is one of the most potent FLT3 inhibitors. FLT3 (Fms-like tyrosine kinase 3, CD135) is a cytokine receptor that belongs to the receptor tyrosine kinase…